Total Cystectomy for Bladder Cancer and 5 year Survival Rate.
- Author:
Woo Soon PARK
1
;
Sung Choon LEE
Author Information
1. Department of Urology, Keimyung University, Medical College and Hospital, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
transitional cell carcinoma;
bladder cancer;
total cystectomy
- MeSH:
Adenocarcinoma;
Carcinoma, Squamous Cell;
Carcinoma, Transitional Cell;
Cystectomy*;
Dermatitis;
Female;
Hemorrhage;
Hepatic Encephalopathy;
Humans;
Hydronephrosis;
Ileus;
Incidence;
Intestinal Fistula;
Intestinal Obstruction;
Lymph Node Excision;
Male;
Mortality;
Pneumothorax;
Pulmonary Embolism;
Renal Insufficiency;
Survival Rate*;
Ulcer;
Urinary Bladder Neoplasms*;
Urinary Bladder*;
Urology;
Wound Infection;
Wounds and Injuries
- From:Korean Journal of Urology
1983;24(2):268-272
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Between Jan, 1971 and July, 1977, 28 consecutive patients underwent total cystectomy and ureteroileocutaneostomy for carcinoma of the bladder in the Department of Urology. Keimyung University Medical College and Hospital, and survival was valuated in 25 patients who had been followed for at least 5 years. 1. Patients ranged in age from 31 years to 72 years, with an average of 53.6 years with peak incidence in the 6th decade and the male to female ratio was 3:1. 2. Preoperative irradiation and pelvic lymphadenectomy were not performed. 3. Operative mortality was 7.1 percent. 4. Early complications included wound infection. wound dehiscence, ileus, intestinal obstruction, pulmonary embolism, rectal injury, spontaneously pneumothorax, hydropneumothroax, renal failure, and hepatic coma. Late complications included parastromal dermatitis, stromal ulceration, recurrent stromal bleeding, fecal fistula, intestinal obstruction and hydronephrosis. 5. The over all 5-year survival rate was 32 percent. The over all 5-year survival rate for patients with transitional cell carcinoma wag 33.3 percent, for squamous cell carcinoma 25 percent, and for adenocarcinoma 33.3 percent. 6. The 5-year survival rate for patients with superficial (A and B1) transitional cell tumor was 80 percent, for B2 and C tumor 11 percent and for D 25 percent. 7. The 5-year survival rate for patients with grade II tumor wag 57 percent, for grade III 17 percent, and for grade IV 20 percent.
